{
 "as_of": "2026-11-08",
 "cmr": "us-cm-kg/NASDAQ/ZYBT",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Zhengye Biotechnology Holding Ltd (NASDAQ: ZYBT) — research page\n\nAs of 2026-11-08 · us-cm-kg · record version 1\n\n## Identity and listing\n\nZhengye Biotechnology Holding Ltd is listed on NASDAQ under ticker ZYBT, with ISIN USG989MS1017. The record holds no LEI, which is not on the record (no GLEIF record with the exact legal name in jurisdiction US-F4). Its security type is Non-operating entity type (other), sector 2834 Pharmaceutical Preparations, jurisdiction China, and segment not on the record. Status: listed, not halted.\n\n## The disclosure read\n\nThe record holds 19 filings in the window 2025-11-08 to 2026-11-08, on 11 filing days: 11 directors' dealings and 8 results. The median gap between filing days is 18.5 days. The latest filing is a results filing dated 2026-08-06, 94 days before the record date of 2026-11-08. The NASDAQ median is 52 filings, 6.0 days cadence gap and 5.0 days latency across 4359 issuers. The sector median for 2834 Pharmaceutical Preparations is 63.0 filings, 6.0 days cadence gap and 4.0 days latency across 526 issuers.\n\n## Auditor\n\nThe auditor is not on the record (no dei:AuditorName tag on the latest annual report cover; foreign private issuers and older filings carry none), and its location is not on the record. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting, name change or segment move lines. Domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). Segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. Halt flag: listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable: the chapter's orderability section carries no client categories, so the outcome cannot name its client category. Rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, chapter as of 2026-11-04.\n\n## Coverage\n\nThe record holds no research houses named on the issuer's investor-relations page; none was found on the pages read. The count is 0.\n\n## Open research\n\nThe record holds no openly published research notes; none was found. The count is 0.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe issuer's years sealed are 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)\n- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)\n- https://data.sec.gov/submissions/CIK0001975641.json (identity.jurisdiction)\n- https://mcp.us-cm-kg.ai/events/NASDAQ/ZYBT (the disclosure lines)\n- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)\n- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.us-cm-kg.ai/record/NASDAQ/ZYBT (the record)\n",
 "market": "US",
 "node": "us-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "live_record_began": "2026-09-12",
   "node_history_from": "2021-01-04",
   "node_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "record_version": 1,
   "sealed": true
  },
  "auditor": {
   "auditor": {
    "market": "US",
    "reason": "no dei:AuditorName tag on the latest annual report cover (foreign private issuers and older filings carry none)",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "US",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "US",
    "state": "not_on_record"
   },
   "changes": []
  },
  "cmr": "us-cm-kg/NASDAQ/ZYBT",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-11",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 4359,
     "median_cadence_gap_days": 6,
     "median_filings": 52,
     "median_latency_days": 5,
     "name": "NASDAQ"
    },
    "sector": {
     "issuers": 526,
     "median_cadence_gap_days": 6,
     "median_filings": 63,
     "median_latency_days": 4,
     "name": "2834 Pharmaceutical Preparations"
    }
   },
   "by_type": {
    "directors_dealings": 11,
    "results": 8
   },
   "cadence_median_gap_days": 18.5,
   "filing_days": 11,
   "filings": 19,
   "latency_days": 94,
   "latest": [
    {
     "category": "6-K",
     "date": "2026-08-06",
     "source": "https://www.sec.gov/Archives/edgar/data/1975641/000121390026086146/ea0300942-6k_zhengye.htm",
     "title": "6-K — REPORT OF FOREIGN PRIVATE ISSUER",
     "type": "results"
    },
    {
     "category": "6-K",
     "date": "2026-07-21",
     "source": "https://www.sec.gov/Archives/edgar/data/1975641/000121390026080010/ea0298686-6k_zhengye.htm",
     "title": "6-K — REPORT OF FOREIGN PRIVATE ISSUER",
     "type": "results"
    },
    {
     "category": "3",
     "date": "2026-06-25",
     "source": "https://www.sec.gov/Archives/edgar/data/1975641/000121390026071870/xslF345X06/ownership.xml",
     "title": "3",
     "type": "directors_dealings"
    },
    {
     "category": "3",
     "date": "2026-06-25",
     "source": "https://www.sec.gov/Archives/edgar/data/1975641/000121390026071868/xslF345X06/ownership.xml",
     "title": "3",
     "type": "directors_dealings"
    },
    {
     "category": "3",
     "date": "2026-06-25",
     "source": "https://www.sec.gov/Archives/edgar/data/1975641/000121390026071867/xslF345X06/ownership.xml",
     "title": "3",
     "type": "directors_dealings"
    }
   ],
   "latest_filing_date": "2026-08-06",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/ZYBT",
   "window": {
    "from": "2025-11-08",
    "to": "2026-11-08"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NASDAQ"
   },
   "isin": {
    "read_by": "SEC Fails-to-Deliver data (CUSIP for the symbol) · ISIN = US + CUSIP + ISO 6166 check digit",
    "read_date": "2026-10-14",
    "read_date_basis": "last_seen",
    "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data",
    "state": "sourced",
    "value": "USG989MS1017"
   },
   "jurisdiction": {
    "read_by": "EDGAR submissions API (issuer header as filed) (stateOfIncorporation)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001975641.json",
    "state": "sourced",
    "value": "China"
   },
   "lei": {
    "market": "US",
    "reason": "no GLEIF record with the exact legal name in jurisdiction US-F4",
    "state": "not_on_record"
   },
   "name": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001975641.json",
    "state": "sourced",
    "value": "Zhengye Biotechnology Holding Ltd"
   },
   "sector": {
    "read_by": "EDGAR submissions API (issuer header as filed) (SIC code as assigned by the SEC)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001975641.json",
    "state": "sourced",
    "value": "2834 Pharmaceutical Preparations"
   },
   "security_type": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001975641.json",
    "state": "sourced",
    "value": "Non-operating entity type (other)"
   },
   "segment": {
    "market": "US",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "ZYBT"
   },
   "website": {
    "market": "US",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": {
    "market": "US",
    "reason": "EDGAR states no dated change of state of incorporation on a filing line",
    "state": "not_on_record"
   },
   "listing": [],
   "name_change": [],
   "segment_move": {
    "market": "US",
    "reason": "the exchanges' tier transfers are not EDGAR filings",
    "state": "not_on_record"
   }
  },
  "market": "US",
  "node": "us-cm-kg",
  "numbers_hash": "sha256:f7ca0d311c17738942fd84934f11d3747c0b65a4a684819dd89fe60f28649e7e",
  "open_research": {
   "read_date": "2026-11-11",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.us-cm-kg.ai/book/aio.json",
    "door": "https://mcp.us-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1",
   "section": "us.aio.v8"
  },
  "record": {
   "as_of": "2026-11-08",
   "url": "https://mcp.us-cm-kg.ai/record/NASDAQ/ZYBT",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:f7ca0d311c17738942fd84934f11d3747c0b65a4a684819dd89fe60f28649e7e",
 "path": "/us/NASDAQ/ZYBT",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "Zhengye Biotechnology Holding Ltd is listed on NASDAQ under ticker ZYBT, with ISIN USG989MS1017. The record holds no LEI, which is not on the record (no GLEIF record with the exact legal name in jurisdiction US-F4). Its security type is Non-operating entity type (other), sector 2834 Pharmaceutical Preparations, jurisdiction China, and segment not on the record. Status: listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 19 filings in the window 2025-11-08 to 2026-11-08, on 11 filing days: 11 directors' dealings and 8 results. The median gap between filing days is 18.5 days. The latest filing is a results filing dated 2026-08-06, 94 days before the record date of 2026-11-08. The NASDAQ median is 52 filings, 6.0 days cadence gap and 5.0 days latency across 4359 issuers. The sector median for 2834 Pharmaceutical Preparations is 63.0 filings, 6.0 days cadence gap and 4.0 days latency across 526 issuers.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor is not on the record (no dei:AuditorName tag on the latest annual report cover; foreign private issuers and older filings carry none), and its location is not on the record. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds no listing, delisting, name change or segment move lines. Domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). Segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. Halt flag: listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable: the chapter's orderability section carries no client categories, so the outcome cannot name its client category. Rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, chapter as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The record holds no research houses named on the issuer's investor-relations page; none was found on the pages read. The count is 0.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "The record holds no openly published research notes; none was found. The count is 0.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The issuer's years sealed are 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.sec.gov/files/company_tickers_exchange.json"
  },
  {
   "for": "identity.isin",
   "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.sec.gov/submissions/CIK0001975641.json"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/ZYBT"
  },
  {
   "for": "the halt flag",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.us-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.us-cm-kg.ai/record/NASDAQ/ZYBT"
  }
 ],
 "title": "Zhengye Biotechnology Holding Ltd (ZYBT) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}